The Procter & Gamble Company (NYSE:PG) Stock Holdings Lessened by Auxier Asset Management

Auxier Asset Management cut its stake in shares of The Procter & Gamble Company (NYSE:PG) by 0.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,854 shares of the company’s stock after selling 70 shares during the quarter. Auxier Asset Management’s holdings in Procter & Gamble were worth $3,274,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Westwood Holdings Group Inc. increased its position in shares of Procter & Gamble by 9.8% in the second quarter. Westwood Holdings Group Inc. now owns 7,863 shares of the company’s stock worth $1,297,000 after acquiring an additional 705 shares in the last quarter. Asset Management Group Inc. boosted its stake in Procter & Gamble by 0.5% in the 2nd quarter. Asset Management Group Inc. now owns 13,606 shares of the company’s stock worth $2,244,000 after purchasing an additional 69 shares during the period. TPG Advisors LLC purchased a new position in Procter & Gamble during the 2nd quarter worth approximately $204,000. Kiely Wealth Advisory Group Inc. raised its stake in Procter & Gamble by 12.3% during the 2nd quarter. Kiely Wealth Advisory Group Inc. now owns 1,808 shares of the company’s stock valued at $309,000 after purchasing an additional 198 shares during the period. Finally, Ameritas Investment Partners Inc. boosted its position in shares of Procter & Gamble by 1.4% in the second quarter. Ameritas Investment Partners Inc. now owns 56,081 shares of the company’s stock worth $9,249,000 after buying an additional 764 shares during the period. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Procter & Gamble Trading Up 1.6 %

Shares of PG stock opened at $174.22 on Friday. The business’s 50 day moving average is $170.21 and its two-hundred day moving average is $165.69. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51. The Procter & Gamble Company has a 12 month low of $141.45 and a 12 month high of $177.94. The company has a market cap of $411.18 billion, a PE ratio of 28.47, a price-to-earnings-growth ratio of 3.84 and a beta of 0.41.

Procter & Gamble (NYSE:PG) last announced its earnings results on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, topping the consensus estimate of $1.37 by $0.03. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The firm had revenue of $20.53 billion for the quarter, compared to the consensus estimate of $20.69 billion. During the same quarter last year, the firm posted $1.37 EPS. The business’s quarterly revenue was down .1% on a year-over-year basis. Equities analysts predict that The Procter & Gamble Company will post 6.97 EPS for the current year.

Procter & Gamble Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Friday, July 19th were issued a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a yield of 2.31%. The ex-dividend date was Friday, July 19th. Procter & Gamble’s dividend payout ratio (DPR) is currently 65.69%.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the company. Royal Bank of Canada upped their price target on Procter & Gamble from $157.00 to $164.00 and gave the company a “sector perform” rating in a research report on Wednesday, July 31st. TD Cowen began coverage on shares of Procter & Gamble in a research report on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 price target for the company. Citigroup boosted their price objective on shares of Procter & Gamble from $177.00 to $190.00 and gave the company a “buy” rating in a research report on Wednesday, July 10th. Evercore ISI increased their target price on shares of Procter & Gamble from $177.00 to $183.00 and gave the stock an “outperform” rating in a research report on Thursday, July 18th. Finally, JPMorgan Chase & Co. boosted their price target on shares of Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a report on Thursday. Seven investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $176.16.

Insiders Place Their Bets

In other news, insider Balaji Purushothaman sold 8,842 shares of the firm’s stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the sale, the insider now owns 11,537 shares in the company, valued at $1,902,451.30. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the completion of the transaction, the insider now owns 11,537 shares of the company’s stock, valued at $1,902,451.30. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Jon R. Moeller sold 37,240 shares of Procter & Gamble stock in a transaction dated Wednesday, August 28th. The stock was sold at an average price of $168.89, for a total value of $6,289,463.60. Following the sale, the chief executive officer now directly owns 263,537 shares in the company, valued at $44,508,763.93. The disclosure for this sale can be found here. Insiders have sold a total of 375,553 shares of company stock valued at $63,829,141 in the last three months. Company insiders own 0.17% of the company’s stock.

About Procter & Gamble

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.